Degree of Joint Risk Factor Control and Incident Heart Failure in Hypertensive Patients

Minghao Kou1, Xuan Wang1, Hao Ma1

  • 1Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, USA.

JACC. Heart Failure
|March 9, 2023
PubMed

Insights

Controlling multiple cardiovascular risk factors significantly lowers heart failure (HF) risk in hypertensive patients. Optimal control of six or more factors can eliminate the excess HF risk associated with hypertension.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Epidemiology

Background:

  • Heart failure (HF) is a significant complication in individuals with hypertension.
  • Hypertension management is crucial for preventing cardiovascular events.

Purpose of the Study:

  • To assess how controlling multiple risk factors impacts hypertension-related HF risk.
  • To determine the effectiveness of joint risk factor management in mitigating HF incidence.

Main Methods:

  • Utilized UK Biobank data from 75,293 hypertensive and 256,619 non-hypertensive individuals.
  • Assessed joint risk factor control (blood pressure, BMI, cholesterol, HbA1c, albuminuria, smoking, physical activity).
  • Employed Cox proportional hazards models to analyze associations between risk factor control and HF risk.

Main Results:

  • Each additional controlled risk factor reduced incident HF risk by 20%.
  • Optimal control (≥6 factors) was linked to a 62% lower HF risk (HR: 0.38).
  • Optimal control eliminated the excess HF risk in hypertensive patients compared to controls (HR: 0.79).

Conclusions:

  • Joint risk factor control cumulatively reduces HF risk, with stronger effects in men.
  • Optimal risk factor management can potentially eliminate hypertension-related excess HF risk.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
27
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
18
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
23